SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-016816
Filing Date
2008-03-11
Accepted
2008-03-11 17:26:34
Documents
5
Period of Report
2008-03-06
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-7923_18k.htm 8-K 41664
2 EX-3.1 a08-7923_1ex3d1.htm EX-3.1 13885
3 EX-3.2 a08-7923_1ex3d2.htm EX-3.2 18196
4 EX-99.1 a08-7923_1ex99d1.htm EX-99.1 25798
5 GRAPHIC g79231mmi001.gif GRAPHIC 6078
  Complete submission text file 0001104659-08-016816.txt   110072
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 08681612
SIC: 2835 In Vitro & In Vivo Diagnostic Substances